July 25, 2019 | Inside Health Policy
Acting U.S. Food and Drug Administration Commissioner Ned Sharpless told agency staff in an email on July 23 that his top priorities are to develop frameworks for regulating new technologies; invest in the agency's workforce; help to lower drug prices by encouraging drug competition; and improve postmarket surveillance of regulated products. In an article published by Inside Health Policy, ML Strategies Senior Director Aaron Josephson commented extensively on Sharpless’ priority list.
A Look at Five Cases at the International Trade Commission: Apple v. Qualcomm, Jurisdiction Issues, and Overlap with the FDA
July 19, 2019 | IPWatchdog
Case filings at the U.S. International Trade Commission (ITC), a popular venue for resolving intellectual property disputes, reached record levels in 2018, and 2019 appears likely to be another busy year. Mintz Member Aarti Shah authored this article published by IPWatchdog that examines a number of important decisions at the ITC, including one in Qualcomm’s high-profile battle with Apple relating to the public interest, among others.
July 16, 2019 | Society for Human Resource Management
In a May 17 article published by the Society for Human Resource Management, Mintz Member and Founding Chair of the firm’s Immigration Practice Susan Cohen commented on President Trump’s merit-based immigration proposal, which could make permanent residency available to more foreign national workers.
July 16, 2019 | Law360
John Quill has joined Mintz’s office in Boston, where he will focus on business immigration matters and improving immigration data reporting. The firm’s Immigration Practice attorneys serve as trusted business advisors for top-tier companies with offices throughout the world.